Epidural steroid injections: efficacy and safety
Procedural · G4c · Reviewed by a board-certified pain physician on October 31, 2026
Bottom line
Epidural steroids give a small, short-term benefit for lumbosacral radicular pain. Their rare catastrophic risks are embolic, so use nonparticulate dexamethasone for transforaminal injections, and do not do high-risk levels without contrast.
Key points
- Expect modest, short-lived benefit. A Cochrane review of 25 placebo-controlled trials found epidural steroids probably slightly reduce leg pain and disability at short-term follow-up, by less than 10 points on a 0–100 scale 1.
- Particulate steroid is the embolic hazard. Catastrophic cord and brain infarctions after cervical transforaminal injection are attributed to particulate steroid entering a vertebral or radicular artery; an FDA-convened working group advised nonparticulate steroid 2.
- Steroid labels carry a warning. Triamcinolone labeling warns of spinal cord infarction, paraplegia, quadriplegia, cortical blindness and stroke after epidural use, with and without fluoroscopy, and states epidural use is not approved 3.
- Contrast unavailability changes the plan. Transforaminal injections at L2 and above, atlanto-axial and atlanto-occipital joint injections and sympathetic blocks should be postponed without contrast because of radiculomedullary artery risk 4.
- Below L2, only nonparticulate steroid without contrast. If a lower transforaminal injection proceeds without contrast, use only a nonparticulate steroid such as dexamethasone 4.
- Interlaminar without contrast: drop the local anesthetic. Consider omitting local anesthetic to avoid a high or total spinal if dura is breached; this is strongly recommended for cervical interlaminar injections 4.
Watch for
Gadolinium is not a safe substitute for iodinated contrast in epidural injections: intrathecal gadolinium is neurotoxic and can be catastrophic 4.
High-yield for the exam
- The 2015 working group combined the FDA Safe Use Initiative, an expert panel and 13 societies, producing 17 clinical considerations 2.
- Lumbar interlaminar injections and medial branch blocks are lowest-importance procedures that may proceed without contrast 4.
- Without contrast, consider preservative-free dexamethasone because preservative-containing steroid given intrathecally is linked to arachnoiditis 4.
- Do not draw contrast from the same vial for multiple patients, because of infection risk 4.
- Minor adverse events reported after epidural steroids included post-dural puncture headache, vasovagal reactions and hypotension 1.
- The Cochrane effects were judged too small to be clinically important for many patients and clinicians 1.
- One trial reported a retroperitoneal hematoma in a patient on anticoagulant therapy 1.
- Cervical transforaminal injections and stellate blocks may be done without contrast only by experts using ultrasound to see arteries 4.
Numbers to know
| Item | Value |
|---|---|
| Cochrane trials | 25 trials, 2470 participants 1 |
| Leg pain difference, short term | −4.93 on 0–100 1 |
| Disability difference, short term | −4.18 on 0–100 1 |
| Short-term window | >2 weeks to ≤3 months 1 |
| Highest-risk transforaminal levels | cervical, thoracic, L2 and above 4 |
| Working group considerations | 17 2 |
| Minor adverse events vs placebo | RR 1.14 (very low quality) 1 |
Common traps
- Choosing particulate triamcinolone for a cervical transforaminal injection 2.
- Switching to a transforaminal approach when contrast is unavailable 4.
- Assuming fluoroscopy alone prevents catastrophic events; label reports occurred with and without it 3.
- Promising long-lasting relief from a single epidural steroid 1.
Practise this topic
5 more questions on this topic in the full question bank, with explanations and sources.
Sources
- Oliveira CB, et al. Epidural corticosteroid injections for lumbosacral radicular pain. Cochrane Database Syst Rev, 2020. pubmed.ncbi.nlm.nih.gov/32271952/
- Rathmell JP, et al. Safeguards to prevent neurologic complications after epidural steroid injections: consensus opinions from a multidisciplinary working group and national organizations. Anesthesiology, 2015. pubmed.ncbi.nlm.nih.gov/25668411/
- US Food and Drug Administration. KENALOG-40 and KENALOG-80 (triamcinolone acetonide injectable suspension) prescribing information. DailyMed, 2024. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf970688-cd
- Schuster NM, et al. Best practices for interventional pain procedures in the setting of an iodinated contrast media shortage: a multisociety practice advisory. Interv Pain Med, 2022. pmc.ncbi.nlm.nih.gov/articles/PMC11372943/
Related topics
Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.